“Regulatory risks are waning in the sector,†says Abhishek Sharma, pharma analyst at IIFL. Hereon, things are expected to move in positive direction for companies.
first published: Jul 11, 2016 09:04 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

